Eldorado Hotel & Spa Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

Vascular Biology and Human Diseases: From Molecular Pathways to Novel Therapeutics  (J8)

joint with the meeting on Uncomplicating Diabetes: Reducing the Burden of Diabetes-Related End-Organ Injury (J7)

Scientific Organizers: Elisabetta Dejana, Anne C. Eichmann and Gavin O. Thurston


February 25—March 1, 2018

Eldorado Hotel & Spa, Santa Fe, New Mexico, USA


Sponsored by Regeneron Pharmaceuticals, Inc.


Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email info@keystonesymposia.org if you are interested.
BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.

DEADLINES:
*All deadlines end at 11:59 PM US Mountain Standard Time
Scholarship Deadline: Nov 16, 2017 [details]
Discounted Abstract Deadline: Nov 16, 2017 [details]
Abstract Deadline: Nov 28, 2017 [details]
Discounted Registration Deadline: Dec 20, 2017 [details]

Click here to view Cancellation Policy

Register Yourself Deadlines and Fees

Rates and Deadlines listed below are for the 2018-J8 "Vascular Biology and Human Diseases: From Molecular Pathways to Novel Therapeutics " conference only.

*All deadlines end at 11:59 PM US Mountain Standard Time

Deadline Date Cost
Discounted Abstract Deadline
More details
Before and On November 16, 2017 100.00 USD*
- 50.00 USD discount
Abstract Deadline
More details
After November 16, 2017 until January 14, 2018 100.00 USD*
* 50.00 USD of Abstract fee deducted from your registration fee when you register for this meeting
Scholarship
More details
November 16, 2017 n/a
Discounted NON-STUDENT Registration
More details
Before and On December 20, 2017 820.00 USD
(includes 200.00 discount)
Regular NON-STUDENT Registration
More details
After December 20, 2017 1020.00 USD
Discounted STUDENT Registration
More details
Before and On December 20, 2017 595.00 USD
(includes 200.00 discount)
Regular STUDENT Registration
More details
After December 20, 2017 795.00 USD

* Changes in payment type that result in a refund are subject to a processing fee.
* Currency exchange gains/losses are the responsibility of the registrant and the Keystone Symposia will accept no liability for money loss through bank charges, transfers or currency fluctuations.




Discounted Abstract Deadline: November 16, 2017

*All deadlines end at 11:59 PM US Mountain Standard Time

Abstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register

Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract early allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • accept your abstract online
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
(The Abstract Deadline: is November 28, 2017)

Global Health Travel Award Deadline:

*All deadlines end at 11:59 PM US Mountain Standard Time


Global Health Travel Award Details: You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline and complete the other required steps (verify your contact information and submit a recommendation letter) to be considered for a travel award.


Click here to learn more about Global Health Travel Awards.

Scholarship Deadline: November 16, 2017

*All deadlines end at 11:59 PM US Mountain Standard Time


Scholarship Details: You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.

Click here to learn more about Scholarships.

Abstract Deadline: November 28, 2017

*All deadlines end at 11:59 PM US Mountain Standard Time


Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register

Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract by the Abstract Deadline allows us to:

  • submit your abstract to organizers to be considered for a short talk
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.

(Discounted Abstract Deadline: is November 16, 2017)

Discounted Registration Deadline: December 20, 2017

*All deadlines end at 11:59 PM US Mountain Standard Time


Registration Fee: 820.00 USD* (includes 200.00 USD discount)
Student Registration Fee: 595.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

After the Discounted Registration Deadline:


Registration Fee: 1020.00 USD*
Student Registration Fee: 795.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

Registration spaces are limited and may fill prior to discounted registration deadline.

Please be advised that a few meeting participants have received calls and emails from a number of different housing services - "Exhibitors Housing Services", "Global Housing", etc. THESE COMPANIES ARE NOT AFFILIATED WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting is filling and seek to take your lodging reservation and obtain your credit card number. We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report to Keystone Symposia any calls or correspondence you might have received and book only through the lodging link on our website, an established travel agency, or directly with the hotel.
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 24 hr (international) time


The meeting will begin on Sunday, February 25 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, March 1 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Friday, March 2 in order to fully experience the meeting.

SUNDAY, FEBRUARY 25

4:00—8:00 PM
Arrival and Registration

Eldorado Lounge
6:00—8:00 PM
Welcome Mixer
No registration fees are used to fund alcohol served at this function.

Eldorado Lounge

MONDAY, FEBRUARY 26

7:00—8:00 AM
Breakfast

Anasazi Ballroom
8:00—9:00 AM
Welcome and Keynote Address
Registered attendees can view abstracts starting on 01/25/2018

Eldorado A
* Elisabetta Dejana, Uppsala University, Sweden

Kari K. Alitalo, University of Helsinki, Finland
Therapeutic Potential of Vascular Growth Factors

8:00—9:00 AM
Welcome and Keynote Address
Registered attendees can view abstracts starting on 01/25/2018

Eldorado B
* Daniel J. Drucker, Lunenfeld-Tanenbaum Research Institute, Canada

Steven E. Kahn, University of Washington, USA
Current Management of Type 2 Diabetes

9:00—11:30 AM
Vascular Growth Factors: Biological Relevance and Therapeutic Application
Registered attendees can view abstracts starting on 01/25/2018

Eldorado A
* Anne C. Eichmann, Yale University School of Medicine, USA

Michael Simons, Yale University, USA
Cell Type Specificity of FGF/TGF Signaling

Coffee Break

Lena Claesson-Welsh, Uppsala University, Sweden
Vascular Leakage in Cancer and Retinopathy

Shahin Rafii, Weill Cornell Medical College, USA
Ultradian Vascular Niche Signals in Organotypic Stem Cell Regeneration

Anna I. Dimberg, Uppsala University Hospital, Sweden
Short Talk: CD93 in Regulation of Tumor Angiogenesis

Roxana Ola, Yale University, USA
Short Talk: Smad4 Acts Downstream of BMP9/10-ALK1 in Mediating AVM Formation through Transcriptional Modulation of CK2/PTEN/PI3K Signaling Cascade

9:00—11:30 AM
New Treatments in Diabetes
Registered attendees can view abstracts starting on 01/25/2018

Eldorado B
* Mark I. McCarthy, University of Oxford, UK

Daniel J. Drucker, Lunenfeld-Tanenbaum Research Institute, Canada
GLP-1-Mediated Reduction in Complications of Diabetes

Coffee Break

Volker Vallon, University of California, San Diego, USA
SGLT2 Inhibition – Insights from Experimental Studies

David Cherney, University of Toronto, Canada
SGLT2 Inhibition: Renal Effects in Man

* Simeon Taylor, University of Maryland School of Medicine, USA
Short Talk: Canagliflozin Triggers the FGF23/1,25-dihydroxyvitamin/PTH Axis: A Potential Mechanism Mediating Adverse Effects on Bone Health

Anita C. Aperia, Karolinska Institute, Sweden
Short Talk: Vulnerability of SGLT-Expressing Cells to Hyperglycaemia

11:30 AM—5:00 PM
On Own for Lunch

11:30 AM—1:00 PM
Poster Setup

Anasazi Ballroom
1:00—10:00 PM
Poster Viewing

Anasazi Ballroom
4:30—5:00 PM
Coffee Available

Concourse
5:00—7:00 PM
Vascular Growth Factors: Receptors and Biological Role
Registered attendees can view abstracts starting on 01/25/2018

Eldorado A
* Lena Claesson-Welsh, Uppsala University, Sweden

Gou Young Koh, Institute of Basic Science, South Korea
Tie2-Activating Antibody “ABTAA” for Micro-vascular Diseases

Gavin O. Thurston, Regeneron Pharmaceuticals Inc., USA
Tumor Endothelial Cell Heterogeneity and Responses to Anti-Vascular Therapy

Luisa Iruela-Arispe, University of California, Los Angeles, USA
Critical Signaling Nodes in Vascular Homeostasis

Hong Chen, Harvard Medical School, USA
Short Talk: Epsin’s Role in Diabetic Lymphanagiogenesis

5:00—7:00 PM
Lipids and Diabetic Complications
Registered attendees can view abstracts starting on 01/25/2018

Eldorado B
* Moshe Levi, University of Colorado Health Sciences Center, USA

* Josephine Forbes, University of Queensland, Australia

Katalin Susztak, University of Pennsylvania, USA
How to Turn GWAS Signals into Drugs for Kidney Disease?

Weier Qi, Joslin Diabetes Center, Harvard Medical School, Boston, USA
Human Proteomics to Therapeutics for Diabetic Nephropathy - The 50-Year Joslin Medalist Study

Eoin P. Brennan, Conway Institute, Ireland
Short Talk: Targeting Inflammation in Diabetic Kidney Disease Using Pro-Resolving Lipid Mediators

7:00—8:00 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Anasazi Ballroom
7:30—10:00 PM
Poster Session 1

Anasazi Ballroom

TUESDAY, FEBRUARY 27

7:00—8:00 AM
Breakfast

Anasazi Ballroom
8:00—11:15 AM
Endothelial Metabolism and Neurovascular Cross-Talk (Joint)
Registered attendees can view abstracts starting on 01/25/2018

Eldorado Grand Ballroom
* George L. King, Joslin Diabetes Center, USA

* Luisa Iruela-Arispe, University of California, Los Angeles, USA

Peter F. Carmeliet, University of Leuven, VIB, Belgium
Endothelial Cell Metabolism and Therapeutic Interventions

Susan Quaggin, Northwestern University, USA
VE-PTP Phosphatase Inhibition Protects the Kidney in Diabetes

Coffee Break

Anne C. Eichmann, Yale University School of Medicine, USA
Neurovascular Cross-Talk and Possible Pathological Implications

David L. Silver, Duke-NUS Medical School, Singapore
Brain Lipid Transport

Kevin G. Peters, Aerpio Pharmaceuticals, USA
Short Talk: Targeting VE-PTP for Tie2 Activation and Vascular Stabilization in Diabetic Eye Disease

Jacqueline A. Taylor, German Cancer Research Center, Germany
Short Talk: Endothelial Notch1 Is a Potent Regulator of Adipose Tissue Metabolism and Function

11:15 AM—5:00 PM
On Own for Lunch

11:15 AM—1:00 PM
Poster Setup

Anasazi Ballroom
1:00—10:00 PM
Poster Viewing

Anasazi Ballroom
4:30—5:00 PM
Coffee Available

Concourse
5:00—7:00 PM
Regulation of Endothelial Cell Differentiation in Development and Tissue Regeneration
Registered attendees can view abstracts starting on 01/25/2018

Eldorado A
* Ralf H. Adams, Max Planck Institute for Molecular Biomedicine, Germany

Didier Stainier, Max Planck Institute for Heart and Lung Research, Germany
Vascular Development in Zebrafish

Taija Mäkinen, Uppsala University, Sweden
Mechanisms of Lymphatic Vessel Formation from Progenitors of Different Origins

Hellmut G. Augustin, DKFZ & Heidelberg University, Germany
Epigenetic Regulation of Vascular Maturation

Katsuhiro Kato, Max Planck Institute for Molecular Biomedicine, Germany
Short Talk: Pulmonary Pericytes Regulate Lung Morphogenesis

5:00—7:15 PM
Mitochondria and Diabetic Complications
Registered attendees can view abstracts starting on 01/25/2018

Eldorado B
* Kumar Sharma, University of Texas Health San Antonio, USA

* Assaad Antoine Eid, American University of Beirut, Lebanon

Richard J. Youle, NINDS, National Institutes of Health, USA
General Overview on Mito Maven

Chengxue Helena Qin, Baker IDI Heart and Diabetes Institute, Australia
Role of Endogenous Annexin-A1 in the Cardiovascular Response to Diabetes

Farhad Danesh, University of Texas MD Anderson Cancer Center, USA
Mitochondrial Reprogramming in Diabetic Nephropathy

Svati H. Shah, Duke University, USA
What Can We Learn from Metabolomics?

7:00—8:00 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Anasazi Ballroom
7:30—10:00 PM
Poster Session 2

Anasazi Ballroom

WEDNESDAY, FEBRUARY 28

7:00—8:00 AM
Breakfast

Anasazi Ballroom
8:00—11:15 AM
Molecular Basis of Vascular Diversity
Registered attendees can view abstracts starting on 01/25/2018

Eldorado A
* Hellmut G. Augustin, DKFZ & Heidelberg University, Germany

Ralf H. Adams, Max Planck Institute for Molecular Biomedicine, Germany
Organ-Specific and Functional Specialization of Blood Vessels

Costantino Iadecola, Weill Cornell Medicine, USA
The Diversity of the Brain Microcirculation in Health and Disease

Coffee Break

Britta Engelhardt, Theodor Kocher Institute/Universitat Bern, Switzerland
Specialized Brain Barriers Establish the Immune Privilege of the CNS

Stefan Liebner, Klinikum der Johann Wolfgang Goethe-Universität, Germany
Role of Astrocyte-derived Wnt Growth Factors for Endothelial Blood-brain Barrier Maintenance

Marco Castro, Uppsala University, Sweden
Short Talk: Endothelial Loss of CDC42 Elicits Cerebral Vascular Malformations and Increases MEKK3-Dependent KLF2/4 Expression

Joseph M. Rutkowski, Texas A&M College of Medicine, USA
Short Talk: Enhancing Renal Lymphatic Expansion Prevents Hypertension in Mice

8:00—11:00 AM
Genomics and Epigenomics in Diabetic Complications
Registered attendees can view abstracts starting on 01/25/2018

Eldorado B
* Katalin Susztak, University of Pennsylvania, USA

* Matthias G. von Herrath, Novo Nordisk and La Jolla Institute for Allergy and Immunology, USA

Eske Willerslev, University of Copenhagen, Denmark
DNA Research on Indigenous Populations

Mark I. McCarthy, University of Oxford, UK
Using Human Genetics for Biological Insight and Translational Advantage

Coffee Break

Ariela Benigni, Istituto di Ricerche Farmacologiche Mario Negri, Italy
Regeneration of Kidney Vasculature by Angiotensin II Antagonism: New Insights

Assam El-Osta, Monash University, Australia
Epigenetics of Diabetes and its Complications: Beyond Epiphenomenon?

11:15 AM—5:00 PM
On Own for Lunch

11:15 AM—1:00 PM
Poster Setup

Anasazi Ballroom
1:00—10:00 PM
Poster Viewing

Anasazi Ballroom
2:30—4:30 PM
Workshop: Blood-Brain Barrier Development and Maintenance in Health and Disease

Eldorado A
* Peetra Ulrica Magnusson, Uppsala University, Sweden

* Dritan Agalliu, Columbia University Medical Center, USA

Ruchi Bajpai, University of Southern California, USA
Cranial Pericytes Derived from Neural Crest Cells Reveal a Pericyte-Specific Functional Defect in Alzheimer’s Disease

Ayal Ben-Zvi, Hebrew University of Jerusalem, Israel
Brain Barrier Pathology in Neuropsychiatric Lupus (NPSLE)

Lei Liu Conze, Uppsala University, Sweden
Dynamic Molecular Signatures of Cerebral Blood Vessel during Blood Brain Barrier Development

Selasi Dankwa, Center for Infectious Disease Research, USA
Identifying Host Kinases and Inhibitors that Regulate Barrier Properties in Human Brain Endothelial Cells

Louise Delsing, University of Skövde, Sweden
A Human iPSC-Derived Model to Investigate Blood-Brain Barrier Specification of Endothelial Cells

Evelyn M. Hoover, University of California, Irvine, USA
The Vascular Immune Response to Infection Differs in the Brain and the Periphery

Andrei V. Karginov, University of Illinois at Chicago, USA
Barrier-Enhancing Function of Src Kinase in Endothelial Cells

Joppe Oldenburg, Uppsala University, Sweden
Identifying Novel Small Molecule Drugs for Cerebral Cavernous Malformation Treatment

4:30—5:00 PM
Coffee Available

Concourse
5:00—7:00 PM
Brain Vascular Pathology
Registered attendees can view abstracts starting on 01/25/2018

Eldorado A
* Costantino Iadecola, Weill Cornell Medicine, USA

Christer Betsholtz, Uppsala University, Sweden
A Molecular Atlas of the Blood-Brain Barrier as Revealed by Single Cell RNA Sequencing and Quantitative Proteomics

Elisabetta Dejana, Uppsala University, Sweden
Transcriptional Regulation of the Blood-Brain Barrier in Health and Disease

Dritan Agalliu, Columbia University Medical Center, USA
Cell Biological Mechanisms of Blood-Brain Barrier Breakdown in Neurological Disease

Monica Manglani, NINDS, National Institutes of Health, USA
Short Talk: Peptide-Specific Engagement of Cerebrovascular Endothelial Cells Promotes Dysfunctional Calcium Signaling during Experimental Cerebral Malaria

5:00—7:00 PM
Oxidative Stress and Diabetic Complications
Registered attendees can view abstracts starting on 01/25/2018

Eldorado B
* Farhad Danesh, University of Texas MD Anderson Cancer Center, USA

* Charles E. Alpers, University of Washington, USA

Patrick J. Pagano, University of Pittsburgh, USA
ROS in Vascular Phenotypic Switching and Disease, Target Nox!

Karin Agnes Maria Jandeleit-Dahm, Monash University, Australia
The Role of Reactive Oxygen Species in Diabetic Complications

Kumar Sharma, University of Texas Health San Antonio, USA
Mitochondrial ROS: Friend or Foe?

Jay C. Jha, Monash University, Australia
Short Talk: NADPH-Oxidase NOX5 Aggravates Renal Injury in Human Diabetic Nephropathy

7:00—8:00 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Anasazi Ballroom
7:30—10:00 PM
Poster Session 3

Anasazi Ballroom

THURSDAY, MARCH 1

7:00—8:00 AM
Breakfast

Anasazi Ballroom
8:00—11:15 AM
Inflammation, the Vasculature and Diabetic Complications (Joint)
Registered attendees can view abstracts starting on 01/25/2018

Eldorado Grand Ballroom
* Anil Karihaloo, Novo Nordisk A/S, USA

* Michael Simons, Yale University, USA

Andrew J. Murphy, Baker Heart Research Institute, Australia
Hematopoietic Progenitor Cells in Diabetic Complications

Mark E. Cooper, Monash University, Australia
An Unrecognized Role for the Adaptive Immune System in Vision-Threatening Neovascular Retinopathies

Coffee Break

Thomas J. Schall, ChemoCentryx, Inc., USA
Targeting CCR2 for Treatment of Renal Diseases

Kyung (Kim) Lee, Icahn School of Medicine at Mount Sinai, USA
Short Talk: Leucine Rich alpha-2-Glycoprotein 1 (LRG1) Is Increased in Diabetic Kidneys and Is a Driver of Angiogenesis and Progression of Diabetic Glomerulopathy

Jill Badin, Indiana University School of Medicine, USA
Short Talk: Diabetes Exacerbates Coronary Atherosclerosis and Calcification in Ossabaw Miniature Swine with Metabolic Syndrome

Ingrid Fleming, Goethe University Frankfurt, Germany
Short Talk: Inhibition of Soluble Epoxide Hydrolase Prevents Diabetic Retinopathy

Reiner Alois Wimmer, IMBA - Institute of Molecular Biotechnology Austria, Austria
Short Talk: Human Blood Vessel Organoids: A New Model for Diabetic Vasculopathy

11:15 AM—5:00 PM
On Own for Lunch

4:30—5:00 PM
Coffee Available

Concourse
5:00—6:45 PM
Hemodynamics and Endothelial Pathology
Registered attendees can view abstracts starting on 01/25/2018

Eldorado A
* Christer Betsholtz, Uppsala University, Sweden

Martin Schwartz, Yale School of Medicine, USA
Endothelial Fluid Shear Stress Responses in Vascular Remodeling and Atherosclerosis

Naoki Mochizuki, National Cerebral and Cardiovascular Center Research Institute, Japan
The Responses of Endothelial Cells to the Flow

Tatiana V. Petrova, CHUV, University of Lausanne, Switzerland
Endothelial Cell Responses to Biomechanical Forces in Lymphatics

5:00—6:45 PM
Vasoactive Hormones in Diabetic Complications
Registered attendees can view abstracts starting on 01/25/2018

Eldorado B
* Susan Quaggin, Northwestern University, USA

Rama Natarajan, Beckman Research Institute of City of Hope, USA
Linking LncRNAs with Diabetic Complications and Angiotensin II Actions

Susan Gurley, Oregon Health and Science University, USA
Angiotensin II: Tissue-Selective Effects

Merlin Christopher Thomas, Monash University, Australia
Novel Interactions with the Receptor for Advanced Glycation End-products in Mediating Pro-inflammatory Signalling

6:45—7:00 PM
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 01/25/2018

Eldorado A
6:45—7:00 PM
Meeting Wrap-Up: Outcomes and Future Directions
Registered attendees can view abstracts starting on 01/25/2018

Eldorado B
* Steven E. Kahn, University of Washington, USA

* Mark E. Cooper, Monash University, Australia

* Matthias G. von Herrath, Novo Nordisk and La Jolla Institute for Allergy and Immunology, USA

* Susan Quaggin, Northwestern University, USA

7:00—8:00 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Anasazi Ballroom
8:00—11:00 PM
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Anasazi Ballroom

FRIDAY, MARCH 2

 
Departure


*Session Chair †Invited, not yet responded.



We gratefully acknowledge support for this conference from:


Directors' Fund


These generous unrestricted gifts allow our Directors to schedule meetings in a wide variety of important areas, many of which are in the early stages of research.

Click here to view all of the donors who support the Directors' Fund.



Keystone Symposia thanks our Sponsor for generously supporting this meeting:

Regeneron Pharmaceuticals, Inc.

We gratefully acknowledge the generous grant for this conference provided by:


National Institutes of Health

Grant No. 1 R13 HL140903-01

Funding for this conference was made possible (in part) by 1 R13 HL140903-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.


We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676